- Accelerating Treatment Development
Lead >
ing the >
Development of >
Targeted Therapies in Cancer >
Our team is dedicated to the development of innovative antibody treatments designed to challenge and revolutionize cancer care.
Explore our innovative science
Seamless, Cutting-edge Therapeutic Solutions
We leverage scientific innovation and unrivaled expertise to create comprehensive, future-forward cancer treatments. We’re committed to not just fighting cancer, but also to improving the quality of life for patients.
Discover Superior Therapeutics
We're dedicated to pioneering breakthrough antibody therapeutics.
Our commitment to rigorous scientific exploration and our relentless pursuit of excellence pave the way for exceptional cancer treatment options.
Invest in Pioneering Healthcare
Our innovative approaches redefine value in oncology.
By investing in our breakthrough therapeutics, you're part of a movement that strives to significantly impact patient lives and propel cancer care into a new era.
Monitor Therapeutic Advancements
Stay updated on our latest scientific endeavors and breakthroughs.
From development to delivery, our transparent processes ensure you're always informed about our progressive strides in transforming oncology.
New targets are needed...
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths.
LB01
A novel target for checkpoint inhibition in leukemia and solid tumors.
LB02
A novel target selectively expressed on leukemic cells.
LB03
An innate immune checkpoint inhibitor.
...to efficiently treat where we fail today.
Discover with Lead Biologics